期刊
DRUG METABOLISM AND PHARMACOKINETICS
卷 26, 期 2, 页码 171-179出版社
JAPANESE SOC STUDY XENOBIOTICS
DOI: 10.2133/dmpk.DMPK-10-RG-073
关键词
intestinal absorption; HMG-CoA reductase inhibitors; pitavastatin; naringin; OATP1A2; OATP2B1; Oatp1a5; Oatp2b1; MDR1; Mdr1a
资金
- Japan Society for the Promotion of Science (JSPS) [21790147]
The purpose of this study was to investigate the involvement of organic anion transporting polypeptide (OATP/Oatp) and P-glycoprotein (P-gp)/multidrug resistance 1 (MDR1/Mdr1) in intestinal absorption of pitavastatin. Pitavastatin was found to be a substrate for human OATP1A2, OATP2B1, and MDR1 and rat Oatp1a5, Oatp2b1, and Mdr1a in experiments using transporter-expressing Xenopus oocytes and LLC-PK1 cell systems. Naringin inhibited Oatpla5- and Mdr1a-mediated transport of pitavastatin with IC50 values of 18.5 and 541 mu M, respectively. The difference in the IC50 values of naringin for Oatp1a5 and Mdr1a-mediated pitavastatin transport may account for the complex concentration-dependent effect of naringin on the intestinal absorption of pitavastatin. Rat intestinal permeability of pitavastatin measured by the in situ closed-loop perfusion method was indeed significantly reduced by 200 mu M naringin, but was significantly increased by 1000 mu M naringin. Furthermore, the permeability was significantly increased by elacridar, a potent inhibitor of Mdr1, while the permeability was significantly decreased in the presence of both elacridar and naringin, suggesting that Oatp1a5 and Mdr1a are both involved in intestinal absorption of pitavastatin. Our present results indicate that OATP/Oatp and MDR1/Mdr1 play roles in the intestinal absorption of pitavastatin as influx and efflux transporters, respectively.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据